|
Molecular properties generated using the CDK |
References |
1. Brazeau JF, Rosse G. (2014)
Novel cycloalkenepyrazoles as inhibitors of bub1 kinase. ACS Med Chem Lett, 5 (4): 280-1. [PMID:24900824] |
2. Hitchcock M, Hilger C-S, Mengel A, Briem H, Holton S, P¨:tter V, Siemeister G, Prechtl S, FERNÁNDEZ-MONTALVÁN AE, Stegmann C. (2013)
Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer. Patent number: WO2013167698. Assignee: Bayer Pharma Aktiengesellschaft. Priority date: 11/05/2012. Publication date: 14/11/2013. |